MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
DNA — Ginkgo Bioworks Holdings, Inc.
NYSEGinkgo Bioworks Holdings, Inc.
$12.35
-0.15(-1.20%)
- O
- 13.00
- H
- 13.40
- L
- 11.94
- V
- 2.03M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About DNA
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SectorNot available
IPO DateApr 19, 2021
Employees485
Stock ExchangeNYSE
Ticker SymbolDNA
Key Financial Statistics
| Market Cap | $831.65M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $5.37 - $17.58 |
| 52-Week Avg Volume | 1.26M |
| VWAP | $12.44 |
| Transactions | 19,993 |
| Total Recorded Bars | 1,372 days |